Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
mem 1003 (2 trials)
rg3487 (3 trials)
Alzheimer Disease (Phase 2)
Bipolar Disorder (Phase 2)
Cognitive Dysfunction (Phase 2)
Schizophrenia (Phase 2)
Trials (5 total)
Trial APIs (2 total)